Emily Earlenbaugh, Contributor

Author's posts

Preclinical Trials On Synthetic Cannabinoid Drug For Covid-19 Suggest Benefits For Treating Lung Inflammation

This week, Tetra Bio-Pharma announced that they had completed preclinical trials on the experimental synthetic cannabinoid drug, and the results suggest it could be helpful for reducing inflammation, scarring and damage in the lungs.

Cannabis Use Not Associated With Increased Risk For Ischemic Stroke In Recent Study

A new study from the University of Mississippi found no evidence for the supposed connection; adding to the research suggesting that cannabis is not an independent risk factor for ischemic stroke.

Medical Cannabis Use For Mental Health Increased During Covid-19 Pandemic, Study Finds

A new study from the Journal of Addictive Diseases is highlighting one way that people are trying to cope with the stressful situation of the Covid-19 pandemic- using cannabis.

Medical Cannabis Use For Mental Health Increased During Covid-19 Pandemic, Study Finds

A new study from the Journal of Addictive Diseases is highlighting one way that people are trying to cope with the stressful situation of the Covid-19 pandemic- using cannabis.

Unlike Opioids, Chronic Cannabis Use Doesn’t Lead To Heightened Pain Sensitivity

Could cannabis be a more attractive alternative for chronic pain relief? A new study suggests that cannabis, unlike opioids, doesn’t lead to heightened pain sensitivity over time.

Synthetic Cannabinoid Drug For Covid-19 Approved For Phase-1 Clinical Trials

In recent months, some have pointed to cannabis as a possible treatment for severe cases of the Covid-19 – pointing specifically towards the cannabinoid CBD. Now, a synthetic cannabinoid drug, ARDS-003, has been given approval by the FDA to begin phase…